top of page

Biotech & Pharma

Placeholder Image


Arvinas is a clinical-stage biopharmaceutical company leading the way in targeted protein degradation therapeutics.

Thermo Fisher Scientific

Thermo Fisher Scientific is the world leader in serving science, generating >$35 billion in annual revenue.

Artizan Biosciences

Artizan Biosciences identifies and distinguishes bacteria in the gut that predispose people to disease with the goal of developing new and potentially curative treatments for unmet medical needs.

Placeholder Image


AtlasXomics, a 2020 Yale spin-out, is commercializing a novel discovery platform that provides clinicians and researchers with unprecedented multi-omics tissue atlases.

Placeholder Image


Cellino is on a mission to make stem cell-based regenerative medicines accessible for all eligible patients.


We are a team of experienced scientists and innovators, passionate about helping to solve significant human health challenges through biomedical research.

From our commitment to knowing and improving the human condition through science comes our name: Virscio (vir’sio)


From global research discoveries to clinical breakthroughs – our vision is to become the most influential life sciences company for researchers.

Dyno Therapeutics

Dyno is a biotech start-up located in Watertown, MA, and we are focusing on pioneering an artificial intelligence (AI) powered approach to gene therapy.

Fate Therapeutics

Fate Therapeutics (Nasdaq: FATE) is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for patients with cancer.


Schrödinger is a leading provider of advanced molecular simulations and enterprise software solutions and services for pharmaceutical, biotechnology, and materials science research.


Superhuman cell biology is changing the course of advanced medicines and complex diseases that have hampered humanity. Our systems and customers are leveraging the super human cells in all of us to advance human health. Our systems, which uniquely reveal these superhuman cells through single-cell & proteomic innovations, are enabling customers to advance the future of medicines against complex disease.


AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.

bottom of page